Surgical Science Sweden AB (FRA:4P41) EBIT : €12.69 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Surgical Science Sweden AB EBIT?

Surgical Science Sweden AB's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2024 was €3.40 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was €12.69 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Surgical Science Sweden AB's annualized ROC % for the quarter that ended in Dec. 2024 was 3.31%. Surgical Science Sweden AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 114.60%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Surgical Science Sweden AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 2.64%.

Surgical Science Sweden AB EBIT Historical Data

The historical data trend for Surgical Science Sweden AB's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgical Science Sweden AB EBIT Chart

Surgical Science Sweden AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT

Get a 7-Day Free Trial

1.99

6.49

19.05

16.91

12.55

Surgical Science Sweden AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EBIT	Get a 7-Day Free Trial															3.37	2.30	2.96	4.03	3.40

Competitive Comparison of Surgical Science Sweden AB's EBIT

For the Health Information Services subindustry, Surgical Science Sweden AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Surgical Science Sweden AB's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Surgical Science Sweden AB's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Surgical Science Sweden AB EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €12.69 Mil.

Surgical Science Sweden AB (FRA:4P41) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Surgical Science Sweden AB's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

	ROC % (Q: Dec. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2024 )	+	Invested Capital (Q: Dec. 2024 ))	/ count )
=	13.608 * ( 1 - 8.02% )	/	( (364.321	+	392.217)	/ 2 )
=	12.5166384	/	378.269
=	3.31 %

where

	Invested Capital		(Q: Sep. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	423.013	-	0	-	( 58.692	-	max(0, 21.477	-	95.355	+	58.692	))
=	364.321

	Invested Capital		(Q: Dec. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	476.385	-	0	-	( 84.168	-	max(0, 24.109	-	123.972	+	84.168	))
=	392.217

Note: The Operating Income data used here is four times the quarterly (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Surgical Science Sweden AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2024		Q: Dec. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	13.608	/	( ( (6.139 + max(5.395, 0))	+	(8.827 + max(3.387, 0)) )	/	2 )
=	13.608	/	( ( 11.534	+	12.214 )	/	2 )
=	13.608	/	11.874
=	114.60 %

where Working Capital is:

	Working Capital		(Q: Sep. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(11.525	+	15.347	+	1.4210854715202E-14)	-	(0	+	0	+	21.477)
=	5.395

	Working Capital		(Q: Dec. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(11.884	+	15.612	+	-1.4210854715202E-14)	-	(0	+	0	+	24.109)
=	3.387

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Surgical Science Sweden AB's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2024 )
	=	12.691	/	480.287
	=	2.64 %

Surgical Science Sweden AB EBIT Related Terms

Thank you for viewing the detailed overview of Surgical Science Sweden AB's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Surgical Science Sweden AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Surgical Science Sweden AB (FRA:4P41) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

SUSRF:USA SUS:Sweden

Address

Drakegatan 7A, Gothenburg, SWE, SE-412 50

Website

https://www.surgicalscience.com

Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments; Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations, prior to entering the clinical environment and also support and services, and Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments and also simulators for medical device companies.

Surgical Science Sweden AB Headlines

No Headlines